EUVIMEDEUVIMED entdecken
Crossref

The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine

Mohammad Balabandian, Mobin Mohammadi, Arashk Mallahzadeh

Neurology Letters · 2024

DOI: 10.61186/nl.3.1.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology Letters, 2024. Verfasst von Mohammad Balabandian und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Balabandian, M., Mohammadi, M., & Mallahzadeh, A. (2024). The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine. Neurology Letters. https://doi.org/10.61186/nl.3.1.3

Vancouver

Balabandian M, Mohammadi M, Mallahzadeh A. The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine. Neurology Letters. 2024. doi:10.61186/nl.3.1.3

BibTeX
@article{Balabandian2024,
  author = {Balabandian, Mohammad and Mohammadi, Mobin and Mallahzadeh, Arashk},
  title = {The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine},
  journal = {Neurology Letters},
  year = {2024},
  doi = {10.61186/nl.3.1.3}
}
Kostenlos starten →